Total Payments
$54,448
2024 Payments
$361.95
Companies
12
Transactions
33
Medicare Patients
1,950
Medicare Billing
$202,527
Payment Breakdown by Category
Other$32,316 (59.4%)
Education$17,691 (32.5%)
Consulting$3,306 (6.1%)
Food & Beverage$772.92 (1.4%)
Travel$361.95 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $32,316 | 1 | 59.4% |
| Education | $17,691 | 2 | 32.5% |
| Consulting Fee | $3,306 | 2 | 6.1% |
| Food and Beverage | $772.92 | 27 | 1.4% |
| Travel and Lodging | $361.95 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $50,108 | 3 | $0 (2019) |
| AbbVie Inc. | $3,523 | 10 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $361.95 | 1 | $0 (2024) |
| Gilead Sciences Inc | $96.67 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $92.15 | 6 | $0 (2019) |
| Celgene Corporation | $55.00 | 1 | $0 (2019) |
| Shire North American Group Inc | $50.63 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $47.81 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $44.63 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.62 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.95 | 1 | E.R. Squibb & Sons, L.L.C. ($361.95) |
| 2021 | $3,306 | 2 | AbbVie Inc. ($3,306) |
| 2019 | $50,408 | 20 | PFIZER INC. ($50,000) |
| 2018 | $84.28 | 4 | Janssen Biotech, Inc. ($44.63) |
| 2017 | $288.33 | 6 | PFIZER INC. ($108.01) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $361.95 | General |
| 10/22/2021 | AbbVie Inc. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,581.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2021 | AbbVie Inc. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,725.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 08/21/2019 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $25.62 | General |
| 07/09/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2019 | PFIZER INC. | — | Grant | Cash or cash equivalent | $32,315.82 | General |
| 07/01/2019 | PFIZER INC. | — | Education | In-kind items and services | $17,684.18 | General |
| 06/27/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Immunology | ||||||
| 06/13/2019 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/29/2019 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: Hepatitis B Vaccine | ||||||
| 05/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Lower GI | ||||||
| 05/02/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $85.38 | General |
| 05/02/2019 | AbbVie, Inc. | — | Education | In-kind items and services | $7.29 | General |
| 04/18/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 04/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Immunology | ||||||
| 03/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 02/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Immunology | ||||||
| 02/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Lower GI | ||||||
| 02/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Lower GI | ||||||
| 02/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Lower GI | ||||||
| 01/24/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 11/27/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Immunology | ||||||
| 11/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 431 | 451 | $1.0M | $41,757 |
| 2022 | 12 | 499 | 525 | $1.1M | $53,688 |
| 2021 | 12 | 676 | 737 | $1.5M | $71,256 |
| 2020 | 10 | 344 | 389 | $650,485 | $35,826 |
Total Patients
1,950
Total Services
2,102
Medicare Billing
$202,527
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 88 | 91 | $475,801 | $18,398 | 3.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $34,369 | $4,245 | 12.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 51 | $176,307 | $4,207 | 2.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $185,820 | $4,120 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 43 | $6,703 | $3,001 | 44.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 24 | $16,070 | $2,243 | 14.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $82,646 | $2,026 | 2.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $3,739 | $1,262 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $2,506 | $1,044 | 41.6% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2023 | 38 | 40 | $17,948 | $889.82 | 5.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 80 | 81 | $14,508 | $322.39 | 2.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 92 | 92 | $427,002 | $17,492 | 4.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 53 | 53 | $217,033 | $5,778 | 2.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 63 | 63 | $198,083 | $5,113 | 2.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $30,035 | $4,870 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 65 | $10,551 | $4,711 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 29 | 29 | $9,800 | $4,197 | 42.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $87,421 | $2,602 | 3.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $38,625 | $2,339 | 6.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 20 | $4,232 | $2,231 | 52.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 12 | 12 | $27,895 | $2,230 | 8.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 22 | $13,679 | $1,784 | 13.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 91 | 91 | $14,662 | $339.30 | 2.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 133 | 135 | $591,755 | $27,458 | 4.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 92 | 97 | $280,637 | $8,147 | 2.9% |
About Dr. Michael Winter, MD
Dr. Michael Winter, MD is a Gastroenterology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1003172180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Winter, MD has received a total of $54,448 in payments from pharmaceutical and medical device companies, with $361.95 received in 2024. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Grant" ($32,316).
As a Medicare-enrolled provider, Winter has provided services to 1,950 Medicare beneficiaries, totaling 2,102 services with total Medicare billing of $202,527. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lebanon, NH
- Active Since 04/03/2012
- Last Updated 09/05/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1003172180
Products in Payments
- RINVOQ (Biological) $3,306
- Humira (Biological) $123.71
- INFLECTRA (Biological) $108.01
- Epclusa (Drug) $96.67
- Entyvio (Biological) $92.15
- INJECTAFER (Drug) $47.81
- STELARA (Biological) $44.63
- XIFAXAN (Drug) $39.62
- GATTEX (Drug) $28.37
- PENTASA (Drug) $22.26
- Heplisav-B (Drug) $3.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lebanon
Corey Siegel, M.d, M.D
Gastroenterology — Payments: $666,177
Gastroenterology $666,177
Brian Lacy, Ph.d; M.d, PH.D; M.D
Gastroenterology — Payments: $272,238
Gastroenterology $272,238
Audrey Calderwood, Md, MD
Gastroenterology — Payments: $93,062
Gastroenterology $93,062
Dr. Shelby Sullivan, Md, MD
Gastroenterology — Payments: $66,641
Gastroenterology $66,641
Stuart Gordon, M.d, M.D
Gastroenterology — Payments: $66,131
Gastroenterology $66,131
Liam Zakko, M.d, M.D
Gastroenterology — Payments: $32,904
Gastroenterology $32,904